Joel B Schachter
Merck Research Laboratories, USA
Biography
Joel Schachter is currently a Principal Scientist in the Movement Disorders and Translation Group at Merck. Dr Schachter joined Merck in 2009 as Director of Neurology and has held several positions there including head of External Discovery and Preclinical Sciences for Neuroscience (XDPS) and Franchise Collaboration Lead for Neuroscience. In his role within XDPS, he was involved in building effective collaborations with external partners and in execution of preclinical drug discovery programs in the areas of Alzheimer's Disease, Parkinson's Disease, Schizophrenia, and pain/migraine. As Franchise Collaboration Lead, he developed collaborative basic research efforts with academic partners. Prior to his work at Merck, Dr Schachter spent 12 years at Pfizer as a member of the Molecular Sciences Department and the Neurology group where he led project teams for several Alzheimer’s Disease-related drug discovery programs including GSK3, Gamma modulators, and Tau New Targets
Abstract
Abstract : Can Tau Pathobiology be Pheno-copied in a Cellular Expression Model?
